Antonio Ramírez de Arellano

Statistics

Publications

Citations

355

H-Index

Active since

2013

Affiliations

Complejo Hospitalario Torrecárdenas(Current)

Vifor Pharma (Switzerland)

Novo Nordisk (United Kingdom)

Hospital Universitario Virgen Macarena

Universitat Jaume I

Antonio Ramírez de Arellano is an author at Complejo Hospitalario Torrecárdenas specializing in pharmacoeconomics, diabetes mellitus, and cost-effectiveness analysis.

Publications per year

2013–2022

Publications

The Economic Burden of Insulin-Related Hypoglycemia in Spain

Witesh Parekh, Nicki Hoskins, James Baker‐Knight et al. · Diabetes Therapy · 2017 · 32 citations · Full text

Pharmacy, Internal Medicine, Pharmacoeconomics +17

Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost‐effectiveness analysis utilising <scp>AFFIRM‐AHF</scp>

Phil McEwan, Piotr Ponikowski, Jason A. Davis et al. · European Journal of Heart Failure · 2021 · 31 citations · Full text

Pharmacy, Cardiology, Pharmacoeconomics +17

The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland

Thomas Ward, Tray Brown, Ruth D. Lewis et al. · PharmacoEconomics - Open · 2022 · 31 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin

Antonio Pérez, Pedro Mezquita Raya, Antonio Ramírez de Arellano et al. · Diabetes Therapy · 2015 · 30 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Self-Reported Frequency and Impact of Hypoglycemic Events in Spain

Domingo Orozco‐Beltrán, Pedro Mezquita‐Raya, Antonio Ramírez de Arellano · Diabetes Therapy · 2014 · 30 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

1–5 of 15